| CEO Name | Scott A. Smith |
| Nationality | United States |
| Net Worth Estimation | $25 million |
Scott A. Smith's estimated net worth of around $25 million stems from his executive compensation, stock awards, and bonuses accumulated during his leadership roles at various pharmaceutical companies, including his recent appointment as CEO of Viatris Inc. This figure reflects his salary packages, equity holdings, and performance-based incentives reported in public filings and financial disclosures.
Scott A. Smith's estimated net worth of $25,000,000 places him at 25% of the way between the minimum ($10,000,000) and maximum ($90,000,000) CEO net worth estimations in the healthcare business category. His net worth is closer to the lower end among healthcare CEOs.
Business Category: Healthcare
Minimum Net Worth (estimation): 10000000 USD
Maximum Net Worth (estimation): 90000000 USD
Scott A. Smith Performance in Mylan N.V. (now part of Viatris Inc.)
Scott A. Smith, CEO of Mylan N.V. (now part of Viatris Inc.), demonstrated strategic leadership by driving key decision-making that focused on market expansion and operational efficiency. Under his guidance, Mylan pursued significant mergers and product approvals, enhancing the company's competitive position in the global pharmaceutical industry. Smith's impact is evident in Mylan's successful integration into Viatris, positioning the combined entity as a leading player in generic and specialty medicines.
Latest News
Mylan N.V. Merges with Pfizer's Upjohn to Form Viatris Inc.
Mylan N.V. combined with Pfizer's Upjohn business in November 2020 to create Viatris Inc., a global healthcare company focused on expanding access to high-quality medicines. The new leadership includes Michael Goettler as CEO, with Rajiv Malik as President, marking a new era for the company's global operations.
Source: http://www.prnewswire.com/news-releases/viatris-inc-launches-as-a-new-kind-of-healthcare-company-positioned-to-meet-the-worlds-evolving-healthcare-needs-301173260.html